Pneumococcal vaccine reduces serious superbug infections
December 29, 2014
Article at a Glance
- The pneumococcal vaccine is linked with a 62 percent decrease in antibiotic-resistant cases of pneumococcal infections.
- This vaccine is an important step in preventing the spread of antibiotic-resistant superbugs.
- The pneumococcal vaccine is recommended for children under five years old, adults 65 or older, or people with health conditions that put them at a higher risk.
Article Types
Archives
Sign up to our Newsletter
[gravityform id="4" title="false" description="false"]